or Try an Advanced Search...

    Treatment Of Myasthenia Gravis Stocks List

    Symbol Grade Name % Change
    IMVT F Immunovant, Inc. 1.41
    GTBP D GT Biopharma, Inc. -5.64
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Myasthenia Gravis Acquired Hemolytic Anemia Anemia Antibodies Autoimmune Disease Biotechnology Cancer Cancer Therapies Cd22 Eye Eye Diseases Immune System Lectins Life Sciences Medicine Monoclonal Antibodies Monoclonal Antibody Myasthenia Siglec

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Myasthenia Gravis stocks.

    Symbol Grade Name Weight
    SBIO C ALPS Medical Breakthroughs ETF 2.66
    MNTL D Tema Neuroscience and Mental Health ETF 1.46
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 0.87
    XBI D SPDR S&P Biotech ETF 0.62
    NSCS A Nuveen Small Cap Select ETF 0.43
    View all Treatment Of Myasthenia Gravis ETFs...
    Compare ETFs
    Compare BBC to NSCS Compare SBIO to BBC Compare SBIO to MNTL

        Treatment Of Myasthenia Gravis Stocks Recent News

        Date Stock Title
        Nov 21 IMVT Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024?
        Nov 15 GTBP GT Biopharma GAAP EPS of -$1.53
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Myasthenia Gravis Acquired Hemolytic Anemia Anemia Antibodies Autoimmune Disease Biotechnology Cancer Cancer Therapies Cd22 Eye Eye Diseases Immune System Lectins Life Sciences Medicine Monoclonal Antibodies Monoclonal Antibody Myasthenia Siglec
        Treatment Of Myasthenia Gravis

        Treatment of myasthenia gravis typically involves medications, such as cholinesterase inhibitors, immunosuppressants, and corticosteroids, as well as other therapies, such as plasmapheresis and thymectomy. The goal of treatment is to reduce the severity of symptoms and improve the patient's quality of life.

        Browse All Tags